Philips showcases new technologies at TCT

Philips Medical Systems displayed a range of technologies and information systems for cardiac interventional care at the Transcatheter Cardiovascular Therapeutics (TCT) conference this week in Washington, D.C.

Demonstrating compatibility announced this past March, Philips displayed Volcano’s s5i intravascular ultrasound (IVUS) system in its booth.  Philips presented tools to enhance percutaneous coronary intervention (PCI) technique, including its latest version of StentBoost (including both lumen and stent views), as well as Volcano’s interoperable IVUS. IVUS provides detailed and accurate measurements of lumen and vessel size, plaque area and volume, the company said.
 
Philips also demonstrated a new Xper system release that features the new Xper table optimized for hybrid procedures involving both interventionalists and cardiothoracic surgeons. This introduction also marks the production release of Philips CT TrueView. The system allows direct importation of CT angiography (CTA) from Philips Extended Brilliance Workspace, into the Philips Xper cath lab.

The firm held live demonstrations, conducted by John Carroll, MD, of its Live 3D Transesophageal Echo (TEE) application on Wednesday. Carroll is chief of cardiology and director of the Cardiac and Vascular Center at the University of Colorado Hospital, which helped develop the technology.

Philips also showcased its Xcelera R2 cardiovascular information management system. The application provides a scalable central workspace for nearly all imaging modalities used in cardiology and bridges the clinical information gap between diagnostic cardiology, invasive cardiology and electrocardiography management, the company said.

Around the web

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.